SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Biosimulation – the next step in PK modelling embraced by regulators

Computer-based drug modelling is moving from a discovery aid to a clinical tool accepted by regulators, according to pharmacokinetics experts.

AMRI to make Glide's solid dose injectable candidate from ex-Aptuit site

AMRI has won a contract to manufacture a solid dose injection (SDI) formulation for Glide Technologies from its newly acquired UK aseptic facility.

Pharma turning to injectable systems to protect biologics, says Unilife

Big Pharma firms like AbbVie are partnering with delivery device makers to guard against biosimilar competition according to Unilife CEO,  Alan Shortall.

News in brief

Neuland Labs passes US FDA audit

Indian CMO Neuland Labs has passed a US FDA audit at one of its two API plants.

update - GVK is 'respectful' of EMA recommendation and is working with customers

EMA recommends suspending drugs tested by GVK at Hyderabad site

The EMA has called for the suspension or withdrawal of medicines whose approval was based on testing by Indian CRO GVK Biosciences.

Covance's LabCorp distraction will drive opportunities for CRL, says analyst

Investment firm William Blair has upgraded preclinical CRO Charles River Laboratories to ‘outperform’ based on strong toxicology demand and the pending acquisition of Covance.

Spotlight

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway
Competition

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway

Did you know that throughout the nineteenth century, vaccination left a scar known as “the mark of...

Charles River considers re-opening preclinical site in Mass.

Charles River considers re-opening preclinical site in Massachusetts

CRO Charles River Laboratories (CRL) may re-open a preclinical site in Shrewsbury, MA, if demand for the...

Parexel strong book-to-bill 'reassuring' for CRO demand, says analyst

Parexel strong book-to-bill 'reassuring' for CRO demand, says analyst

Parexel’s improved book-to-bill ratio is a reassuring sign for the company and the CRO industry as a whole,...

Crown expands Precos site to build caucasian cancer expertise

Crown expands Precos site to build caucasian cancer expertise

Crown Biosciences has announced plans to double capacity at a site operated by its Precos division.

Oil slump good for API makers, until a major supplier turns off the tap says industry group

Oil slump good for API makers, until a major supplier turns off the tap says industry group

Falling oil prices are good news for firms that make pharmaceutical ingredients according to a European chemical...

Japan to be hot destination for trials in 2015 say experts, despite drop in MRCTs last year

Japan to be hot destination for trials in 2015 say experts, despite drop in MRCTs last year

Japan was involved in fewer drug industry-sponsored multi-regional clinical trials (MRCT) in 2014 than any year since...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...